Recent clinical successes, and profits, have prompted a rush among pharma companies to try new isotopes and targeting strategies
Methodically tracking the collapse. Climate data. Extreme weather. The long emergency.
Recent clinical successes, and profits, have prompted a rush among pharma companies to try new isotopes and targeting strategies